SIMILAR PATTERN OF AMINO ACIDS MAPPED TO '2eh7'

List of Similar Pattern of Amino Acids

Hit pattern: 3D amino acid arrangements similar to known drug binding site
Query pattern: Residues from known binding site for annotated drug that match the hit pattern

(Click on the DrReposER ID to view details on interfaces and similar patterns of amino acids)
(Click on the view link on the last column to view superposed patterns of amino acids)

Filter list by:

	DrReposER ID / Desc.	Hit PDBID	Hit Macromolecule	Res. Matches	Interface	HETATM	RMSD	Dali Z-score	Seq. Identity (%)
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1USQ_A_CLMA1143_0 (DR HEMAGGLUTININ STRUCTURAL SUBUNIT)	2eh7	HUMANIZED KR127 FAB, HEAVY CHAIN (Mus musculus)	5 / 7	GLY H 53 PRO H 52 THR H 57 ILE H 51 GLY H 55	None	1.10A	1usqA-2eh7H: undetectable	1usqA-2eh7H: 18.72
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1USQ_B_CLMB1143_0 (DR HEMAGGLUTININ STRUCTURAL SUBUNIT)	2eh7	HUMANIZED KR127 FAB, HEAVY CHAIN (Mus musculus)	4 / 6	GLY H 53 PRO H 52 ILE H 51 GLY H 55	None	0.80A	1usqB-2eh7H: undetectable	1usqB-2eh7H: 18.72
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1USQ_C_CLMC1143_0 (DR HEMAGGLUTININ STRUCTURAL SUBUNIT)	2eh7	HUMANIZED KR127 FAB, HEAVY CHAIN (Mus musculus)	4 / 6	GLY H 53 PRO H 52 ILE H 51 GLY H 55	None	0.80A	1usqC-2eh7H: undetectable	1usqC-2eh7H: 18.72
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1USQ_D_CLMD1142_0 (DR HEMAGGLUTININ STRUCTURAL SUBUNIT)	2eh7	HUMANIZED KR127 FAB, HEAVY CHAIN (Mus musculus)	4 / 6	GLY H 53 PRO H 52 ILE H 51 GLY H 55	None	0.81A	1usqD-2eh7H: undetectable	1usqD-2eh7H: 18.72
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1USQ_E_CLME1143_0 (DR HEMAGGLUTININ STRUCTURAL SUBUNIT)	2eh7	HUMANIZED KR127 FAB, HEAVY CHAIN (Mus musculus)	4 / 6	GLY H 53 PRO H 52 ILE H 51 GLY H 55	None	0.81A	1usqE-2eh7H: undetectable	1usqE-2eh7H: 18.72
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1USQ_F_CLMF1144_0 (DR HEMAGGLUTININ STRUCTURAL SUBUNIT)	2eh7	HUMANIZED KR127 FAB, HEAVY CHAIN (Mus musculus)	5 / 7	GLY H 53 PRO H 52 THR H 57 ILE H 51 GLY H 55	None	1.09A	1usqF-2eh7H: undetectable	1usqF-2eh7H: 18.72
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2JKJ_B_CLMB1141_0 (DR HEMAGGLUTININ STRUCTURAL SUBUNIT)	2eh7	HUMANIZED KR127 FAB, HEAVY CHAIN (Mus musculus)	4 / 6	GLY H 53 PRO H 52 ILE H 51 GLY H 55	None	0.87A	2jkjB-2eh7H: undetectable	2jkjB-2eh7H: 18.72
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2JKJ_E_CLME1141_0 (DR HEMAGGLUTININ STRUCTURAL SUBUNIT)	2eh7	HUMANIZED KR127 FAB, HEAVY CHAIN (Mus musculus)	5 / 7	GLY H 53 PRO H 52 THR H 57 ILE H 51 GLY H 55	None	1.12A	2jkjE-2eh7H: undetectable	2jkjE-2eh7H: 18.72
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2JKL_A_CLMA1144_0 (DR HEMAGGLUTININ STRUCTURAL SUBUNIT)	2eh7	HUMANIZED KR127 FAB, HEAVY CHAIN (Mus musculus)	5 / 7	GLY H 53 PRO H 52 THR H 57 ILE H 51 GLY H 55	None	1.12A	2jklA-2eh7H: undetectable	2jklA-2eh7H: 18.72
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2JKL_C_CLMC1143_0 (DR HEMAGGLUTININ STRUCTURAL SUBUNIT)	2eh7	HUMANIZED KR127 FAB, HEAVY CHAIN (Mus musculus)	5 / 7	GLY H 53 PRO H 52 THR H 57 ILE H 51 GLY H 55	None	1.12A	2jklC-2eh7H: undetectable	2jklC-2eh7H: 18.72
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2JKL_D_CLMD1145_0 (DR HEMAGGLUTININ STRUCTURAL SUBUNIT)	2eh7	HUMANIZED KR127 FAB, HEAVY CHAIN (Mus musculus)	5 / 7	GLY H 53 PRO H 52 THR H 57 ILE H 51 GLY H 55	None	1.12A	2jklD-2eh7H: undetectable	2jklD-2eh7H: 18.72
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2JKL_E_CLME1143_0 (DR HEMAGGLUTININ STRUCTURAL SUBUNIT)	2eh7	HUMANIZED KR127 FAB, HEAVY CHAIN (Mus musculus)	5 / 7	GLY H 53 PRO H 52 THR H 57 ILE H 51 GLY H 55	None	1.12A	2jklE-2eh7H: undetectable	2jklE-2eh7H: 18.72
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2JKL_F_CLMF1143_0 (DR HEMAGGLUTININ STRUCTURAL SUBUNIT)	2eh7	HUMANIZED KR127 FAB, HEAVY CHAIN (Mus musculus)	5 / 7	GLY H 53 PRO H 52 THR H 57 ILE H 51 GLY H 55	None	1.12A	2jklF-2eh7H: undetectable	2jklF-2eh7H: 18.72
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3HUO_A_PNNA302_0 (CTX-M-9 EXTENDED-SPECTRUM BETA-LACTAMASE)	2eh7	HUMANIZED KR127 FAB, HEAVY CHAIN (Mus musculus)	4 / 6	LEU H 189 GLY H 190 ALA H 125 PRO H 126	None	0.46A	3huoA-2eh7H: undetectable	3huoA-2eh7H: 23.36
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4QVN_H_BO2H301_1 (PROTEASOME SUBUNIT BETA TYPE-2 PROTEASOME SUBUNIT BETA TYPE-3)	2eh7	HUMANIZED KR127 FAB, HEAVY CHAIN (Mus musculus)	5 / 11	SER H 188 GLY H 134 THR H 135 ALA H 136 THR H 131	None	0.94A	4qvnH-2eh7H: undetectable 4qvnI-2eh7H: undetectable	4qvnH-2eh7H: 21.43 4qvnI-2eh7H: 22.84
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4QVN_V_BO2V301_1 (PROTEASOME SUBUNIT BETA TYPE-2 PROTEASOME SUBUNIT BETA TYPE-3)	2eh7	HUMANIZED KR127 FAB, HEAVY CHAIN (Mus musculus)	5 / 10	SER H 188 GLY H 134 THR H 135 ALA H 136 THR H 131	None	0.94A	4qvnV-2eh7H: undetectable 4qvnW-2eh7H: undetectable	4qvnV-2eh7H: 21.43 4qvnW-2eh7H: 22.84
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4QVP_H_BO2H301_1 (PROTEASOME SUBUNIT BETA TYPE-2 PROTEASOME SUBUNIT BETA TYPE-3)	2eh7	HUMANIZED KR127 FAB, HEAVY CHAIN (Mus musculus)	5 / 12	SER H 188 GLY H 134 THR H 135 ALA H 136 THR H 131	None	0.92A	4qvpH-2eh7H: undetectable 4qvpI-2eh7H: undetectable	4qvpH-2eh7H: 21.43 4qvpI-2eh7H: 22.84
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4QVP_V_BO2V301_1 (PROTEASOME SUBUNIT BETA TYPE-2 PROTEASOME SUBUNIT BETA TYPE-3)	2eh7	HUMANIZED KR127 FAB, HEAVY CHAIN (Mus musculus)	5 / 12	SER H 188 GLY H 134 THR H 135 ALA H 136 THR H 131	None	0.92A	4qvpV-2eh7H: undetectable 4qvpW-2eh7H: undetectable	4qvpV-2eh7H: 21.43 4qvpW-2eh7H: 22.84
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4QVQ_H_BO2H301_1 (PROTEASOME SUBUNIT BETA TYPE-2 PROTEASOME SUBUNIT BETA TYPE-3)	2eh7	HUMANIZED KR127 FAB, HEAVY CHAIN (Mus musculus)	5 / 11	SER H 188 GLY H 134 THR H 135 ALA H 136 THR H 131	None	0.94A	4qvqH-2eh7H: undetectable 4qvqI-2eh7H: undetectable	4qvqH-2eh7H: 21.43 4qvqI-2eh7H: 22.84
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4QVQ_V_BO2V301_1 (PROTEASOME SUBUNIT BETA TYPE-2 PROTEASOME SUBUNIT BETA TYPE-3)	2eh7	HUMANIZED KR127 FAB, HEAVY CHAIN (Mus musculus)	5 / 11	SER H 188 GLY H 134 THR H 135 ALA H 136 THR H 131	None	0.93A	4qvqV-2eh7H: undetectable 4qvqW-2eh7H: undetectable	4qvqV-2eh7H: 21.43 4qvqW-2eh7H: 22.84
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4QVV_H_BO2H301_1 (PROTEASOME SUBUNIT BETA TYPE-2)	2eh7	HUMANIZED KR127 FAB, HEAVY CHAIN (Mus musculus)	5 / 11	SER H 188 GLY H 134 THR H 135 ALA H 136 THR H 131	None	0.95A	4qvvH-2eh7H: undetectable	4qvvH-2eh7H: 21.43
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4QVV_V_BO2V301_1 (PROTEASOME SUBUNIT BETA TYPE-2)	2eh7	HUMANIZED KR127 FAB, HEAVY CHAIN (Mus musculus)	5 / 11	SER H 188 GLY H 134 THR H 135 ALA H 136 THR H 131	None	0.94A	4qvvV-2eh7H: undetectable	4qvvV-2eh7H: 21.43
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4QVY_H_BO2H301_1 (PROTEASOME SUBUNIT BETA TYPE-2)	2eh7	HUMANIZED KR127 FAB, HEAVY CHAIN (Mus musculus)	5 / 11	SER H 188 GLY H 134 THR H 135 ALA H 136 THR H 131	None	0.93A	4qvyH-2eh7H: undetectable	4qvyH-2eh7H: 21.43
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4QVY_V_BO2V301_1 (PROTEASOME SUBUNIT BETA TYPE-2 PROTEASOME SUBUNIT BETA TYPE-3)	2eh7	HUMANIZED KR127 FAB, HEAVY CHAIN (Mus musculus)	5 / 12	SER H 188 GLY H 134 THR H 135 ALA H 136 THR H 131	None	0.93A	4qvyV-2eh7H: undetectable 4qvyW-2eh7H: undetectable	4qvyV-2eh7H: 21.43 4qvyW-2eh7H: 22.84
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4QW0_H_BO2H301_1 (PROTEASOME SUBUNIT BETA TYPE-2 PROTEASOME SUBUNIT BETA TYPE-3)	2eh7	HUMANIZED KR127 FAB, HEAVY CHAIN (Mus musculus)	5 / 11	SER H 188 GLY H 134 THR H 135 ALA H 136 THR H 131	None	0.94A	4qw0H-2eh7H: undetectable 4qw0I-2eh7H: undetectable	4qw0H-2eh7H: 21.43 4qw0I-2eh7H: 22.84
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4QW0_V_BO2V301_1 (PROTEASOME SUBUNIT BETA TYPE-2 PROTEASOME SUBUNIT BETA TYPE-3)	2eh7	HUMANIZED KR127 FAB, HEAVY CHAIN (Mus musculus)	5 / 11	SER H 188 GLY H 134 THR H 135 ALA H 136 THR H 131	None	0.94A	4qw0V-2eh7H: undetectable 4qw0W-2eh7H: undetectable	4qw0V-2eh7H: 21.43 4qw0W-2eh7H: 22.84
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4QW1_H_BO2H301_1 (PROTEASOME SUBUNIT BETA TYPE-2 PROTEASOME SUBUNIT BETA TYPE-3)	2eh7	HUMANIZED KR127 FAB, HEAVY CHAIN (Mus musculus)	5 / 12	SER H 188 GLY H 134 THR H 135 ALA H 136 THR H 131	None	0.95A	4qw1H-2eh7H: undetectable 4qw1I-2eh7H: undetectable	4qw1H-2eh7H: 21.43 4qw1I-2eh7H: 22.84
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4QW1_V_BO2V301_1 (PROTEASOME SUBUNIT BETA TYPE-2 PROTEASOME SUBUNIT BETA TYPE-3)	2eh7	HUMANIZED KR127 FAB, HEAVY CHAIN (Mus musculus)	5 / 12	SER H 188 GLY H 134 THR H 135 ALA H 136 THR H 131	None	0.95A	4qw1V-2eh7H: undetectable 4qw1W-2eh7H: undetectable	4qw1V-2eh7H: 21.43 4qw1W-2eh7H: 22.84
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4QWU_H_BO2H301_1 (PROTEASOME SUBUNIT BETA TYPE-2 PROTEASOME SUBUNIT BETA TYPE-3)	2eh7	HUMANIZED KR127 FAB, HEAVY CHAIN (Mus musculus)	5 / 11	SER H 188 GLY H 134 THR H 135 ALA H 136 THR H 131	None	0.94A	4qwuH-2eh7H: undetectable 4qwuI-2eh7H: undetectable	4qwuH-2eh7H: 21.43 4qwuI-2eh7H: 22.84
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4QWU_V_BO2V301_1 (PROTEASOME SUBUNIT BETA TYPE-2 PROTEASOME SUBUNIT BETA TYPE-3)	2eh7	HUMANIZED KR127 FAB, HEAVY CHAIN (Mus musculus)	5 / 11	SER H 188 GLY H 134 THR H 135 ALA H 136 THR H 131	None	0.94A	4qwuV-2eh7H: undetectable 4qwuW-2eh7H: undetectable	4qwuV-2eh7H: 21.43 4qwuW-2eh7H: 22.84
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5BXN_H_BO2H301_1 (PROTEASOME SUBUNIT BETA TYPE-2 PROTEASOME SUBUNIT BETA TYPE-3)	2eh7	HUMANIZED KR127 FAB, HEAVY CHAIN (Mus musculus)	5 / 11	SER H 188 GLY H 134 THR H 135 ALA H 136 THR H 131	None	0.93A	5bxnH-2eh7H: undetectable 5bxnI-2eh7H: undetectable	5bxnH-2eh7H: 21.43 5bxnI-2eh7H: 22.84
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5CZ7_V_BO2V301_1 (PROTEASOME SUBUNIT BETA TYPE-2 PROTEASOME SUBUNIT BETA TYPE-3)	2eh7	HUMANIZED KR127 FAB, HEAVY CHAIN (Mus musculus)	5 / 12	SER H 188 GLY H 134 THR H 135 ALA H 136 THR H 131	None	0.94A	5cz7V-2eh7H: undetectable 5cz7W-2eh7H: undetectable	5cz7V-2eh7H: 21.43 5cz7W-2eh7H: 22.84
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5D0X_V_BO2V301_1 (PROTEASOME SUBUNIT BETA TYPE-2)	2eh7	HUMANIZED KR127 FAB, HEAVY CHAIN (Mus musculus)	5 / 11	SER H 188 GLY H 134 THR H 135 ALA H 136 THR H 131	None	0.92A	5d0xV-2eh7H: undetectable	5d0xV-2eh7H: 21.43
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5L5F_H_BO2H301_1 (PROTEASOME SUBUNIT BETA TYPE-2 PROTEASOME SUBUNIT BETA TYPE-3)	2eh7	HUMANIZED KR127 FAB, HEAVY CHAIN (Mus musculus)	5 / 12	SER H 188 GLY H 134 THR H 135 ALA H 136 THR H 131	None	0.90A	5l5fH-2eh7H: undetectable 5l5fI-2eh7H: undetectable	5l5fH-2eh7H: 21.43 5l5fI-2eh7H: 22.84
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5L5F_V_BO2V301_1 (PROTEASOME SUBUNIT BETA TYPE-2 PROTEASOME SUBUNIT BETA TYPE-3)	2eh7	HUMANIZED KR127 FAB, HEAVY CHAIN (Mus musculus)	5 / 12	SER H 188 GLY H 134 THR H 135 ALA H 136 THR H 131	None	0.90A	5l5fV-2eh7H: undetectable 5l5fW-2eh7H: undetectable	5l5fV-2eh7H: 21.43 5l5fW-2eh7H: 22.84
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6HWD_H_BO2H301_0 (PROTEASOME SUBUNIT BETA TYPE-2 PROTEASOME SUBUNIT BETA TYPE-3)	2eh7	HUMANIZED KR127 FAB, HEAVY CHAIN (Mus musculus)	5 / 12	SER H 188 GLY H 134 THR H 135 ALA H 136 THR H 131	None	1.01A	6hwdH-2eh7H: undetectable 6hwdI-2eh7H: undetectable	6hwdH-2eh7H: 19.90 6hwdI-2eh7H: 15.28
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6HWD_V_BO2V301_0 (PROTEASOME SUBUNIT BETA TYPE-2)	2eh7	HUMANIZED KR127 FAB, HEAVY CHAIN (Mus musculus)	5 / 11	SER H 188 GLY H 134 THR H 135 ALA H 136 THR H 131	None	1.01A	6hwdV-2eh7H: undetectable	6hwdV-2eh7H: 19.90

[["DrReposER ID","Desc.","Hit PDB","Hit molecule","Hit organism","Res. no.","Interface","HETATM","RMSD","Z-score","Seq ID"],["1USQ_A_CLMA1143_0","DR HEMAGGLUTININ STRUCTURAL SUBUNIT","2eh7","HUMANIZED KR127 FAB, HEAVY CHAIN","Mus musculus",5,"GLY H  53;PRO H  52;THR H  57;ILE H  51;GLY H  55","None","1.10A","1usqA-2eh7H:undetectable","1usqA-2eh7H:18.72"],["1USQ_B_CLMB1143_0","DR HEMAGGLUTININ STRUCTURAL SUBUNIT","2eh7","HUMANIZED KR127 FAB, HEAVY CHAIN","Mus musculus",4,"GLY H  53;PRO H  52;ILE H  51;GLY H  55","None","0.80A","1usqB-2eh7H:undetectable","1usqB-2eh7H:18.72"],["1USQ_C_CLMC1143_0","DR HEMAGGLUTININ STRUCTURAL SUBUNIT","2eh7","HUMANIZED KR127 FAB, HEAVY CHAIN","Mus musculus",4,"GLY H  53;PRO H  52;ILE H  51;GLY H  55","None","0.80A","1usqC-2eh7H:undetectable","1usqC-2eh7H:18.72"],["1USQ_D_CLMD1142_0","DR HEMAGGLUTININ STRUCTURAL SUBUNIT","2eh7","HUMANIZED KR127 FAB, HEAVY CHAIN","Mus musculus",4,"GLY H  53;PRO H  52;ILE H  51;GLY H  55","None","0.81A","1usqD-2eh7H:undetectable","1usqD-2eh7H:18.72"],["1USQ_E_CLME1143_0","DR HEMAGGLUTININ STRUCTURAL SUBUNIT","2eh7","HUMANIZED KR127 FAB, HEAVY CHAIN","Mus musculus",4,"GLY H  53;PRO H  52;ILE H  51;GLY H  55","None","0.81A","1usqE-2eh7H:undetectable","1usqE-2eh7H:18.72"],["1USQ_F_CLMF1144_0","DR HEMAGGLUTININ STRUCTURAL SUBUNIT","2eh7","HUMANIZED KR127 FAB, HEAVY CHAIN","Mus musculus",5,"GLY H  53;PRO H  52;THR H  57;ILE H  51;GLY H  55","None","1.09A","1usqF-2eh7H:undetectable","1usqF-2eh7H:18.72"],["2JKJ_B_CLMB1141_0","DR HEMAGGLUTININ STRUCTURAL SUBUNIT","2eh7","HUMANIZED KR127 FAB, HEAVY CHAIN","Mus musculus",4,"GLY H  53;PRO H  52;ILE H  51;GLY H  55","None","0.87A","2jkjB-2eh7H:undetectable","2jkjB-2eh7H:18.72"],["2JKJ_E_CLME1141_0","DR HEMAGGLUTININ STRUCTURAL SUBUNIT","2eh7","HUMANIZED KR127 FAB, HEAVY CHAIN","Mus musculus",5,"GLY H  53;PRO H  52;THR H  57;ILE H  51;GLY H  55","None","1.12A","2jkjE-2eh7H:undetectable","2jkjE-2eh7H:18.72"],["2JKL_A_CLMA1144_0","DR HEMAGGLUTININ STRUCTURAL SUBUNIT","2eh7","HUMANIZED KR127 FAB, HEAVY CHAIN","Mus musculus",5,"GLY H  53;PRO H  52;THR H  57;ILE H  51;GLY H  55","None","1.12A","2jklA-2eh7H:undetectable","2jklA-2eh7H:18.72"],["2JKL_C_CLMC1143_0","DR HEMAGGLUTININ STRUCTURAL SUBUNIT","2eh7","HUMANIZED KR127 FAB, HEAVY CHAIN","Mus musculus",5,"GLY H  53;PRO H  52;THR H  57;ILE H  51;GLY H  55","None","1.12A","2jklC-2eh7H:undetectable","2jklC-2eh7H:18.72"],["2JKL_D_CLMD1145_0","DR HEMAGGLUTININ STRUCTURAL SUBUNIT","2eh7","HUMANIZED KR127 FAB, HEAVY CHAIN","Mus musculus",5,"GLY H  53;PRO H  52;THR H  57;ILE H  51;GLY H  55","None","1.12A","2jklD-2eh7H:undetectable","2jklD-2eh7H:18.72"],["2JKL_E_CLME1143_0","DR HEMAGGLUTININ STRUCTURAL SUBUNIT","2eh7","HUMANIZED KR127 FAB, HEAVY CHAIN","Mus musculus",5,"GLY H  53;PRO H  52;THR H  57;ILE H  51;GLY H  55","None","1.12A","2jklE-2eh7H:undetectable","2jklE-2eh7H:18.72"],["2JKL_F_CLMF1143_0","DR HEMAGGLUTININ STRUCTURAL SUBUNIT","2eh7","HUMANIZED KR127 FAB, HEAVY CHAIN","Mus musculus",5,"GLY H  53;PRO H  52;THR H  57;ILE H  51;GLY H  55","None","1.12A","2jklF-2eh7H:undetectable","2jklF-2eh7H:18.72"],["3HUO_A_PNNA302_0","CTX-M-9 EXTENDED-SPECTRUM BETA-LACTAMASE","2eh7","HUMANIZED KR127 FAB, HEAVY CHAIN","Mus musculus",4,"LEU H 189;GLY H 190;ALA H 125;PRO H 126","None","0.46A","3huoA-2eh7H:undetectable","3huoA-2eh7H:23.36"],["4QVN_H_BO2H301_1","PROTEASOME SUBUNIT BETA TYPE-2;PROTEASOME SUBUNIT BETA TYPE-3","2eh7","HUMANIZED KR127 FAB, HEAVY CHAIN","Mus musculus",5,"SER H 188;GLY H 134;THR H 135;ALA H 136;THR H 131","None","0.94A","4qvnH-2eh7H:undetectable;4qvnI-2eh7H:undetectable","4qvnH-2eh7H:21.43;4qvnI-2eh7H:22.84"],["4QVN_V_BO2V301_1","PROTEASOME SUBUNIT BETA TYPE-2;PROTEASOME SUBUNIT BETA TYPE-3","2eh7","HUMANIZED KR127 FAB, HEAVY CHAIN","Mus musculus",5,"SER H 188;GLY H 134;THR H 135;ALA H 136;THR H 131","None","0.94A","4qvnV-2eh7H:undetectable;4qvnW-2eh7H:undetectable","4qvnV-2eh7H:21.43;4qvnW-2eh7H:22.84"],["4QVP_H_BO2H301_1","PROTEASOME SUBUNIT BETA TYPE-2;PROTEASOME SUBUNIT BETA TYPE-3","2eh7","HUMANIZED KR127 FAB, HEAVY CHAIN","Mus musculus",5,"SER H 188;GLY H 134;THR H 135;ALA H 136;THR H 131","None","0.92A","4qvpH-2eh7H:undetectable;4qvpI-2eh7H:undetectable","4qvpH-2eh7H:21.43;4qvpI-2eh7H:22.84"],["4QVP_V_BO2V301_1","PROTEASOME SUBUNIT BETA TYPE-2;PROTEASOME SUBUNIT BETA TYPE-3","2eh7","HUMANIZED KR127 FAB, HEAVY CHAIN","Mus musculus",5,"SER H 188;GLY H 134;THR H 135;ALA H 136;THR H 131","None","0.92A","4qvpV-2eh7H:undetectable;4qvpW-2eh7H:undetectable","4qvpV-2eh7H:21.43;4qvpW-2eh7H:22.84"],["4QVQ_H_BO2H301_1","PROTEASOME SUBUNIT BETA TYPE-2;PROTEASOME SUBUNIT BETA TYPE-3","2eh7","HUMANIZED KR127 FAB, HEAVY CHAIN","Mus musculus",5,"SER H 188;GLY H 134;THR H 135;ALA H 136;THR H 131","None","0.94A","4qvqH-2eh7H:undetectable;4qvqI-2eh7H:undetectable","4qvqH-2eh7H:21.43;4qvqI-2eh7H:22.84"],["4QVQ_V_BO2V301_1","PROTEASOME SUBUNIT BETA TYPE-2;PROTEASOME SUBUNIT BETA TYPE-3","2eh7","HUMANIZED KR127 FAB, HEAVY CHAIN","Mus musculus",5,"SER H 188;GLY H 134;THR H 135;ALA H 136;THR H 131","None","0.93A","4qvqV-2eh7H:undetectable;4qvqW-2eh7H:undetectable","4qvqV-2eh7H:21.43;4qvqW-2eh7H:22.84"],["4QVV_H_BO2H301_1","PROTEASOME SUBUNIT BETA TYPE-2","2eh7","HUMANIZED KR127 FAB, HEAVY CHAIN","Mus musculus",5,"SER H 188;GLY H 134;THR H 135;ALA H 136;THR H 131","None","0.95A","4qvvH-2eh7H:undetectable","4qvvH-2eh7H:21.43"],["4QVV_V_BO2V301_1","PROTEASOME SUBUNIT BETA TYPE-2","2eh7","HUMANIZED KR127 FAB, HEAVY CHAIN","Mus musculus",5,"SER H 188;GLY H 134;THR H 135;ALA H 136;THR H 131","None","0.94A","4qvvV-2eh7H:undetectable","4qvvV-2eh7H:21.43"],["4QVY_H_BO2H301_1","PROTEASOME SUBUNIT BETA TYPE-2","2eh7","HUMANIZED KR127 FAB, HEAVY CHAIN","Mus musculus",5,"SER H 188;GLY H 134;THR H 135;ALA H 136;THR H 131","None","0.93A","4qvyH-2eh7H:undetectable","4qvyH-2eh7H:21.43"],["4QVY_V_BO2V301_1","PROTEASOME SUBUNIT BETA TYPE-2;PROTEASOME SUBUNIT BETA TYPE-3","2eh7","HUMANIZED KR127 FAB, HEAVY CHAIN","Mus musculus",5,"SER H 188;GLY H 134;THR H 135;ALA H 136;THR H 131","None","0.93A","4qvyV-2eh7H:undetectable;4qvyW-2eh7H:undetectable","4qvyV-2eh7H:21.43;4qvyW-2eh7H:22.84"],["4QW0_H_BO2H301_1","PROTEASOME SUBUNIT BETA TYPE-2;PROTEASOME SUBUNIT BETA TYPE-3","2eh7","HUMANIZED KR127 FAB, HEAVY CHAIN","Mus musculus",5,"SER H 188;GLY H 134;THR H 135;ALA H 136;THR H 131","None","0.94A","4qw0H-2eh7H:undetectable;4qw0I-2eh7H:undetectable","4qw0H-2eh7H:21.43;4qw0I-2eh7H:22.84"],["4QW0_V_BO2V301_1","PROTEASOME SUBUNIT BETA TYPE-2;PROTEASOME SUBUNIT BETA TYPE-3","2eh7","HUMANIZED KR127 FAB, HEAVY CHAIN","Mus musculus",5,"SER H 188;GLY H 134;THR H 135;ALA H 136;THR H 131","None","0.94A","4qw0V-2eh7H:undetectable;4qw0W-2eh7H:undetectable","4qw0V-2eh7H:21.43;4qw0W-2eh7H:22.84"],["4QW1_H_BO2H301_1","PROTEASOME SUBUNIT BETA TYPE-2;PROTEASOME SUBUNIT BETA TYPE-3","2eh7","HUMANIZED KR127 FAB, HEAVY CHAIN","Mus musculus",5,"SER H 188;GLY H 134;THR H 135;ALA H 136;THR H 131","None","0.95A","4qw1H-2eh7H:undetectable;4qw1I-2eh7H:undetectable","4qw1H-2eh7H:21.43;4qw1I-2eh7H:22.84"],["4QW1_V_BO2V301_1","PROTEASOME SUBUNIT BETA TYPE-2;PROTEASOME SUBUNIT BETA TYPE-3","2eh7","HUMANIZED KR127 FAB, HEAVY CHAIN","Mus musculus",5,"SER H 188;GLY H 134;THR H 135;ALA H 136;THR H 131","None","0.95A","4qw1V-2eh7H:undetectable;4qw1W-2eh7H:undetectable","4qw1V-2eh7H:21.43;4qw1W-2eh7H:22.84"],["4QWU_H_BO2H301_1","PROTEASOME SUBUNIT BETA TYPE-2;PROTEASOME SUBUNIT BETA TYPE-3","2eh7","HUMANIZED KR127 FAB, HEAVY CHAIN","Mus musculus",5,"SER H 188;GLY H 134;THR H 135;ALA H 136;THR H 131","None","0.94A","4qwuH-2eh7H:undetectable;4qwuI-2eh7H:undetectable","4qwuH-2eh7H:21.43;4qwuI-2eh7H:22.84"],["4QWU_V_BO2V301_1","PROTEASOME SUBUNIT BETA TYPE-2;PROTEASOME SUBUNIT BETA TYPE-3","2eh7","HUMANIZED KR127 FAB, HEAVY CHAIN","Mus musculus",5,"SER H 188;GLY H 134;THR H 135;ALA H 136;THR H 131","None","0.94A","4qwuV-2eh7H:undetectable;4qwuW-2eh7H:undetectable","4qwuV-2eh7H:21.43;4qwuW-2eh7H:22.84"],["5BXN_H_BO2H301_1","PROTEASOME SUBUNIT BETA TYPE-2;PROTEASOME SUBUNIT BETA TYPE-3","2eh7","HUMANIZED KR127 FAB, HEAVY CHAIN","Mus musculus",5,"SER H 188;GLY H 134;THR H 135;ALA H 136;THR H 131","None","0.93A","5bxnH-2eh7H:undetectable;5bxnI-2eh7H:undetectable","5bxnH-2eh7H:21.43;5bxnI-2eh7H:22.84"],["5CZ7_V_BO2V301_1","PROTEASOME SUBUNIT BETA TYPE-2;PROTEASOME SUBUNIT BETA TYPE-3","2eh7","HUMANIZED KR127 FAB, HEAVY CHAIN","Mus musculus",5,"SER H 188;GLY H 134;THR H 135;ALA H 136;THR H 131","None","0.94A","5cz7V-2eh7H:undetectable;5cz7W-2eh7H:undetectable","5cz7V-2eh7H:21.43;5cz7W-2eh7H:22.84"],["5D0X_V_BO2V301_1","PROTEASOME SUBUNIT BETA TYPE-2","2eh7","HUMANIZED KR127 FAB, HEAVY CHAIN","Mus musculus",5,"SER H 188;GLY H 134;THR H 135;ALA H 136;THR H 131","None","0.92A","5d0xV-2eh7H:undetectable","5d0xV-2eh7H:21.43"],["5L5F_H_BO2H301_1","PROTEASOME SUBUNIT BETA TYPE-2;PROTEASOME SUBUNIT BETA TYPE-3","2eh7","HUMANIZED KR127 FAB, HEAVY CHAIN","Mus musculus",5,"SER H 188;GLY H 134;THR H 135;ALA H 136;THR H 131","None","0.90A","5l5fH-2eh7H:undetectable;5l5fI-2eh7H:undetectable","5l5fH-2eh7H:21.43;5l5fI-2eh7H:22.84"],["5L5F_V_BO2V301_1","PROTEASOME SUBUNIT BETA TYPE-2;PROTEASOME SUBUNIT BETA TYPE-3","2eh7","HUMANIZED KR127 FAB, HEAVY CHAIN","Mus musculus",5,"SER H 188;GLY H 134;THR H 135;ALA H 136;THR H 131","None","0.90A","5l5fV-2eh7H:undetectable;5l5fW-2eh7H:undetectable","5l5fV-2eh7H:21.43;5l5fW-2eh7H:22.84"],["6HWD_H_BO2H301_0","PROTEASOME SUBUNIT BETA TYPE-2;PROTEASOME SUBUNIT BETA TYPE-3","2eh7","HUMANIZED KR127 FAB, HEAVY CHAIN","Mus musculus",5,"SER H 188;GLY H 134;THR H 135;ALA H 136;THR H 131","None","1.01A","6hwdH-2eh7H:undetectable;6hwdI-2eh7H:undetectable","6hwdH-2eh7H:19.90;6hwdI-2eh7H:15.28"],["6HWD_V_BO2V301_0","PROTEASOME SUBUNIT BETA TYPE-2","2eh7","HUMANIZED KR127 FAB, HEAVY CHAIN","Mus musculus",5,"SER H 188;GLY H 134;THR H 135;ALA H 136;THR H 131","None","1.01A","6hwdV-2eh7H:undetectable","6hwdV-2eh7H:19.90"]]